Intervention Review

Perphenazine for schizophrenia

  1. Benno Hartung1,*,
  2. Makoto Wada2,
  3. Gerd Laux3,
  4. Stefan Leucht4

Editorial Group: Cochrane Schizophrenia Group

Published Online: 24 JAN 2005

Assessed as up-to-date: 21 OCT 2004

DOI: 10.1002/14651858.CD003443.pub2


How to Cite

Hartung B, Wada M, Laux G, Leucht S. Perphenazine for schizophrenia. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD003443. DOI: 10.1002/14651858.CD003443.pub2.

Author Information

  1. 1

    Heinrich-Heine-Universitaet Duesseldorf, Institut fuer Rechtsmedizin, Dusselfdorf, Germany

  2. 2

    Kyoto University, Department of Psychiatry, Kyoto, Japan

  3. 3

    Bezirkskrankenhaus Gabersee, Wasserburg, Bavaria, Germany

  4. 4

    Technische Universität München Klinikum rechts der Isar, Klinik und Poliklinik für Psychiatrie und Psychotherapie, München, Germany

*Benno Hartung, Institut fuer Rechtsmedizin, Heinrich-Heine-Universitaet Duesseldorf, Moorenstr. 5, Dusselfdorf, 40225, Germany. benno.hartung@gmx.de. Benno.Hartung@med.uni-duesseldorf.de.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 24 JAN 2005

SEARCH

  1. Current Version

    Perphenazine for schizophrenia

    Benno Hartung, Makoto Wada, Gerd Laux and Stefan Leucht

    Article first published online: 24 JAN 2005 | DOI: 10.1002/14651858.CD003443.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Perphenazine for schizophrenia

    S Leucht and B Hartung

    Article first published online: 23 OCT 2001 | DOI: 10.1002/14651858.CD003443